Taj Pharmaceuticals Ltd. is an Indian Non-Government Company into manufacturing and distribution of medicines, majorly in Generic drug Manufacturing. Founded in 2004 and headquartered in Indian city of Mumbai. The company is led by Abhishek Kumar Singh, initially incorporated as manufacturing flagship company Taj Pharma CIS LLC, Moscow,The company is focused on majorly in medicine relating to cancer/oncology, HIV/AIDS, influenza, Parkinson’s disease, transplantation, pneumonia, BCG vaccine and common diseases. The company said to have received FDA approval for the Drug Papaverine capsules 150mg; indicated for visceral spasm, ANDA for generic Topiramate Tablets and US Patent for the controversial drug Terfenadine, doxorubicin injection. Taj Pharmaceuticals was making patented diabetes drug Vildagliptin in India, which is still a propriety drug of Swiss firm Novartis. The Company was listed as one of the few BCG vaccine manufacturers by the Global Market Survey conducted by World Health Organisation in 2017, BCG vaccine which is primarily used against tuberculosis (TB).
Taj Pharmaceuticals Limited
|Founder||Dr.R K Singh|
|CEO||Abhishek Kumar Singh|
|Key people||Abhishek Kumar Singh, (CEO)|
Shantanu Kumar Singh (CFO)
|Number of employees||5001|
|Telephone||1800-222-434 / 825|
+ +91 22 2637 4592
+91 22 2637 4593
+91 22 2634 1274
The product range includes major generic drugs under therapeutic category such as anti-cancer drugs, CNS drugs; Key category of products includes generic medicines for anemia, anxiety disorders, cancer/oncology, ear infections, heart failure, hepatitis, HIV/AIDS, influenza, non-Hodgkin’s lymphoma, obesity, osteoporosis, Parkinson’s disease, pneumonia, transplantation and common diseases.Major Known competing brand in India against Ranbaxy’s health supplement capsules Revital is Activital Z, a combination of Vitamins, Minerals and Ginseng.
Ms.Priyanka Singh is nominated for the Pharma Leaders Innovative Woman Entrepreneur of the year 2018.
“OMICS International – Business & Management Experts”. OMICS International Business & Management Experts. “RUSSIA BEYOND – Indian drug makers fit into Russia’s pharma strategy”. ALEXANDRA KATZ SPECIALLY FOR RIR. 17 July 2013. “Exclusive TV Interview – Channel TF1 France, Tf1 survey european markets dependence on China and India for medicine supply” (in français). TF1 (France) News Channel. Retrieved 2018-09-30. “News on The Economic Times Profile details and more Taj Pharmaceuticals Limited”. The Economic Times. 18 October 2018. “Review of the available evidence on Imatinib for Inclusion in the WHO Essential Medicines List as an anti-neoplastic agent – India does not recognize Novartis’ patent exclusivity, and imatinib is available in India from Taj Pharmaceuticals Page 4” (PDF). Dana-Farber Cancer Institute Center for Global Cancer Medicine. 17 July 2013. “A Comprehensive Review on Cyclodextrin-Based Carriers for Delivery of Chemotherapeutic Cytotoxic Anticancer – FDA approval for manufacturing of Piroxicam-beta-Cyclodextrin, Nimesulide-beta-cyclodextrin, Aceclofenac-beta-Cyclodextrin generic drugs in regulatory market, and nonregulated market in the year 2009 Drugs”. Bina Gidwani and Amber Vyas *National Center for Biotechnology Information, U.S. National Library of Medicine. 20 March 2013. PMC 4637021. “International Consortium for Emergency Contraception (ICEC)”. International Consortium for Emergency Contraception. 18 October 2018. “Regulatory Affairs (Research) Taj Pharmaceutical – Minutes of Meeting Council Meeting on Drug & Pharmaceutical September 17, 2013 – The Pharma Times”. The Pharma Times News Bureau. 17 July 2013.
“Taj Pharma Opens Chemotherapy Plant in Daman With Rs 100 Cr Investment”. News dog. 20 August 2018. “The Economic Times ET Rise details and more Taj Pharmaceuticals Limited”. The Economic Times – Times Internet Limited. 18 October 2018. “GLOBAL MARKET UPDATE BCG VACCINE – CURRENT MANUFACTURERS BY PQ STATUS WORLD HEALTH ORGANIZATION – MARKET UPDATE – Working Document – April 2017” (PDF). WORLD HEALTH ORGANIZATION, Geneva – Switzerland. Retrieved 2017-11-30. “Bloomberg Company Overview of Taj Pharmaceuticals Limited”. Bloomberg L.P. “Taj Pharma receives FDA approval to manufacture Papaverine”. Pharmaceutical Business Review. 21 October 2011. “APN NEWS-Health Medical News Taj Pharmaceuticals bags US FDA approval for generic Topiramate Tablets”. APN NEWS. 18 August 2018. “Taj Pharmaceuticals Announces Issuance of US Patent for Terfenadine”. News Wire. 5 June 2011. “FDA approval of generic version of cancer drug doxorubicin hydrochloride liposome injection is expected to help resolve shortage of drug supply”. APN News. 20 March 2013. “Novartis restrains local pharma Cos from making patented diabetes drug”. The Times of India. 6 August 2018. “Revital gets a booster dose – Business Standard News”. Business Standard News. 20 January 2013. “Pharma Leaders Innovative Woman Entrepreneur of the year 2018”. Pharmaleaders 2018.
WHO Essential Medicines List Company Inclusion